Naveen Vasudev
- Sensory Systems top 2%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
-
- Renal cell carcinoma treatment 38
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 11
- Pancreatic and Hepatic Oncology Research 5
- Molecular Biology top 10%
- Renal and related cancers 11
-
- Bladder and Urothelial Cancer Treatments 9
-
- MRI in cancer diagnosis 6
-
- Economic and Financial Impacts of Cancer 5
- Co-authors
- Andrew R. ReynoldsRosamonde E. BanksPeter J. SelbyDavid J. BeechHannah J. GauntJon CartledgeDouglas ThompsonJonathan Welti
- Journals
- Journal of Biological Chemistry (2 papers)Angewandte Chemie International Edition (1 paper)Journal of Clinical Oncology (10 papers)
- Partner nations
- United KingdomGermanyJapan
In The Last Decade
Naveen Vasudev
65 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Sensory Systems 154
- Cancer Research 384
- Pulmonary and Respiratory Medicine 490
- Oncology 380
- Molecular Biology 903
Countries citing papers authored by Naveen Vasudev
This map shows the geographic impact of Naveen Vasudev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naveen Vasudev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naveen Vasudev more than expected).
Fields of papers citing papers by Naveen Vasudev
This network shows the impact of papers produced by Naveen Vasudev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naveen Vasudev. The network helps show where Naveen Vasudev may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naveen Vasudev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial | 2022 | 20 |
| 5 | 2022 | 0 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 3 | |
| 10 | 2017 | 20 | |
| 11 | 2016 | 35 | |
| 12 | 2016 | 3 | |
| 13 | 2016 | 40 | |
| 14 | 2015 | 38 | |
| 15 | 2014 | 2 | |
| 16 | 2013 | 36 | |
| 17 | 2010 | 5 | |
| 18 | 2010 | 27 | |
| 19 | 2009 | 24 | |
| 20 | 2008 | 31 |
About Naveen Vasudev
Naveen Vasudev is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 70 papers that have together received 1.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (38 papers), Renal and related cancers (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), Bladder and Urothelial Cancer Treatments (9 papers), Cancer Genomics and Diagnostics (8 papers), MRI in cancer diagnosis (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Economic and Financial Impacts of Cancer (5 papers). The work is most often cited by research in Sensory Systems (154 citations), Cancer Research (384 citations) and Pulmonary and Respiratory Medicine (490 citations). Naveen Vasudev has collaborated with scholars based in United Kingdom, Germany and Japan. Frequent co-authors include Andrew R. Reynolds, Rosamonde E. Banks, Peter J. Selby, David J. Beech, Hannah J. Gaunt, Jon Cartledge, Douglas Thompson, Jonathan Welti, Melanie J. Ludlow and Katsuhiko Muraki. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.